rs117738194

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001845.6(COL4A1):​c.3693G>A​(p.Thr1231Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00687 in 1,610,634 control chromosomes in the GnomAD database, including 445 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 49 hom., cov: 33)
Exomes 𝑓: 0.0067 ( 396 hom. )

Consequence

COL4A1
NM_001845.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.223

Publications

6 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 13-110170596-C-T is Benign according to our data. Variant chr13-110170596-C-T is described in ClinVar as Benign. ClinVar VariationId is 258252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.223 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0688 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.3693G>Ap.Thr1231Thr
synonymous
Exon 42 of 52NP_001836.3P02462-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.3693G>Ap.Thr1231Thr
synonymous
Exon 42 of 52ENSP00000364979.4P02462-1
COL4A1
ENST00000650424.2
c.3693G>Ap.Thr1231Thr
synonymous
Exon 42 of 52ENSP00000497477.2A0A3B3ISV3
COL4A1
ENST00000933608.1
c.3594G>Ap.Thr1198Thr
synonymous
Exon 41 of 51ENSP00000603667.1

Frequencies

GnomAD3 genomes
AF:
0.00862
AC:
1312
AN:
152246
Hom.:
46
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0459
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.0745
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00132
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.0221
AC:
5323
AN:
240386
AF XY:
0.0175
show subpopulations
Gnomad AFR exome
AF:
0.00213
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.00521
Gnomad EAS exome
AF:
0.0822
Gnomad FIN exome
AF:
0.000142
Gnomad NFE exome
AF:
0.00124
Gnomad OTH exome
AF:
0.0163
GnomAD4 exome
AF:
0.00668
AC:
9743
AN:
1458270
Hom.:
396
Cov.:
32
AF XY:
0.00603
AC XY:
4374
AN XY:
725164
show subpopulations
African (AFR)
AF:
0.00123
AC:
41
AN:
33414
American (AMR)
AF:
0.0978
AC:
4322
AN:
44172
Ashkenazi Jewish (ASJ)
AF:
0.00527
AC:
137
AN:
25994
East Asian (EAS)
AF:
0.0722
AC:
2865
AN:
39656
South Asian (SAS)
AF:
0.00130
AC:
111
AN:
85600
European-Finnish (FIN)
AF:
0.000188
AC:
10
AN:
53122
Middle Eastern (MID)
AF:
0.00141
AC:
8
AN:
5684
European-Non Finnish (NFE)
AF:
0.00157
AC:
1747
AN:
1110418
Other (OTH)
AF:
0.00834
AC:
502
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
558
1117
1675
2234
2792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00868
AC:
1323
AN:
152364
Hom.:
49
Cov.:
33
AF XY:
0.00925
AC XY:
689
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00204
AC:
85
AN:
41594
American (AMR)
AF:
0.0464
AC:
711
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.0749
AC:
388
AN:
5180
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00132
AC:
90
AN:
68034
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
59
118
178
237
296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00375
Hom.:
4
Bravo
AF:
0.0145
Asia WGS
AF:
0.0240
AC:
83
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
Brain small vessel disease 1 with or without ocular anomalies (3)
-
-
2
not specified (2)
-
-
1
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
8.1
DANN
Benign
0.43
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117738194; hg19: chr13-110822943; COSMIC: COSV107488281; API